SFX by Ex Libris Inc.

Title:	The Development of a Robust Process for a CRF1Receptor Antagonist
Source:	Organic Process Research & development [1083-6160] Broxer, Sévrine yr:2011

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Smith, Amos B. "Spongistatin Synthetic Studies. An Efficient, Second-Generation Construction of an Advanced ABCD Intermediate." Organic letters 4.5 (2002): 783-786.
description	2.	Regazzoni, L. "Screening of fibrillogenesis inhibitors of beta(2)-microglobulin: Integrated strategies by mass spectrometry capillary electrophoresis and in silico simulations." Analytica Chimica Acta 685.2 (2011): 153-161.
description	3.	Deussen, H. "Process Development and Scale-Up of the PPAR Agonist NNC 61-4655." Organic process research & development 8.3 (2004): 363-.
description	4.	Smith, Amos B. "Total Synthesis of (+)-Spongistatin 1. An Effective Second-Generation Construction of an Advanced EF Wittig Salt, Fragment Union, and Final Elaboration." Organic letters 5.5 (2003): 761-764.
description	5.	miyaoka, H. "total synthesis of antimalarial diterpenoid (+)-kalihinol a." Chemical communications (London. 1996) 48.6 (2012): 901-903.
description	6.	Giorgetti, S. "Effect of Tetracyclines on the Dynamics of Formation and Destructuration of beta 2-Microglobulin Amyloid Fibrils." Journal of biological chemistry 286.3 (2011): 2121-2131.
description	7.	Du, J. "Structural modeling and biochemical studies reveal insights into the molecular basis of the recognition of beta-2-microglobulin by antibody BBM.1." Journal of molecular recognition 22.6 (2009): 465-473.
description	8.	Slee, D. "Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties." Bioorganic and medicinal chemistry letters 20.24 (2010): 7259-7264.
description	9.	Smith, Amos B. "Spongistatin Synthetic Studies. Evolution of a Scalable Synthesis for the EF Fragment of (+)-Spongistatin 1 Exploiting a Petasis-Ferrier Union/Rearrangement Tactic." Organic letters 6.20 (2004): 3637-3640.
description	10.	Smith, Amos B. "Total synthesis of the neotropical poison-frog alkaloid (-)-205B." Organic letters 7.15 (2005): 3247-3250.
description	11.	Schubert, Max H B. "Galantamine Improves Cognition in Schizophrenic Patients Stabilized on Risperidone." Biological psychiatry 60.6: 530-533.
description	12.	Cohen, Fred E E. "Therapeutic approaches to protein-misfolding diseases." Nature 426.6968 (2003): 905-909.
description	13.	Fujiwara, K. "Synthesis and relative stereochemistry of the A- and F-rings of goniodomin A." Bulletin of the Chemical Society of Japan 80.6 (2007): 1173-1186.
description	14.	Liu, L. "Advances in glycoprotein synthesis." Chemical communications online 1 (2006): 21-33.
description	15.	Bucciantini, M. "Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases." Nature 416.6880 (2002): 507-511.
description	16.	Dobson, Christopher M M. "Principles of protein folding, misfolding and aggregation." Seminars in cell & developmental biology 15.1 (2004): 3-16.
description	17.	Hirai, K. "Total Synthesis of (±)-Trachyspic Acid and Determination of the Relative Configuration." Organic letters 5.6 (2003): 857-859.
description	18.	Nilewski, C. "Synthesis of undecachlorosulfolipid A: re-evaluation of the nominal structure." Angewandte Chemie (International ed. in English) 50.34 (2011): 7940-7943.
description	19.	Wagner, Janice D. "A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys." The journal of pharmacology and experimental therapeutics 335.1 (2010): 103-13.
description	20.	MacMillan, John B. "Long-Range Stereo-Relay: Relative and Absolute Configuration of 1,n-Glycols from Circular Dichroism of Liposomal Porphyrin Esters." Journal of the American Chemical Society 126.32 (2004): 9944-9945.